Author

Viktória Szabó

CHARACTERIZATION OF 2D AND 3D DUCTAL ORGANOID CULTURES DERIVED FROM MOUSE AND HUMAN PANCREATIC TISSUES
CHARACTERIZATION OF 2D AND 3D DUCTAL ORGANOID CULTURES DERIVED FROM MOUSE AND HUMAN PANCREATIC TISSUES

Viktória Szabó  et al.

CHARACTERIZATION OF 2D AND 3D DUCTAL ORGANOID CULTURES DERIVED FROM MOUSE AND HUMAN PANCREATIC TISSUES
CHARACTERIZATION OF 2D AND 3D DUCTAL ORGANOID CULTURES DERIVED FROM MOUSE AND HUMAN PANCREATIC TISSUES

INVESTIGATING THE ROLE OF ORAI1 CA2+ CHANNEL IN THE PROGRESSION OF CHRONIC PANCREATITIS
INVESTIGATING THE ROLE OF ORAI1 CA2+ CHANNEL IN THE PROGRESSION OF CHRONIC PANCREATITIS

ORAI1 CALCIUM CHANNEL INHIBITION PREVENTS PROGRESSION OF RECURRENT ACUTE AND CHRONIC PANCREATITIS
ORAI1 CALCIUM CHANNEL INHIBITION PREVENTS PROGRESSION OF RECURRENT ACUTE AND CHRONIC PANCREATITIS

Viktória Szabó  et al.

INHIBITION OF ORAI1 PROTECTS THE PANCREATIC TISSUE AND REDUCES THE PROGRESSION OF FIBROSIS IN CHRONIC PANCREATITIS
INHIBITION OF ORAI1 PROTECTS THE PANCREATIC TISSUE AND REDUCES THE PROGRESSION OF FIBROSIS IN CHRONIC PANCREATITIS

INHIBITION OF ORAI1 PROTECTS THE PANCREATIC TISSUE AND REDUCES THE PROGRESSION OF FIBROSIS IN CHRONIC PANCREATITIS
INHIBITION OF ORAI1 PROTECTS THE PANCREATIC TISSUE AND REDUCES THE PROGRESSION OF FIBROSIS IN CHRONIC PANCREATITIS

Viktória Szabó  et al.

CHANGE IN THE EXPRESSION OF SERPIN E1, A POTENTIAL NEW DISEASE ACTIVITY MARKER, REFLECTS THERAPEUTIC RESPONSE IN INFLAMMATORY BOWEL DISEASE
CHANGE IN THE EXPRESSION OF SERPIN E1, A POTENTIAL NEW DISEASE ACTIVITY MARKER, REFLECTS THERAPEUTIC RESPONSE IN INFLAMMATORY BOWEL DISEASE

Viktória Szabó  et al.

PLASMINOGEN ACTIVATOR INHIBITOR 1 A POTENTIAL NEW THERAPEUTIC TARGET IN THE TREATMENT OF CHRONIC PANCREATITIS
PLASMINOGEN ACTIVATOR INHIBITOR 1 A POTENTIAL NEW THERAPEUTIC TARGET IN THE TREATMENT OF CHRONIC PANCREATITIS

Viktória Szabó  et al.

INCREASED EXPRESSION OF SERPIN E1, A POTENTIAL NEW ACTIVITY MARKER, REFLECTS ENDOSCOPIC ACTIVITY AND THERAPEUTIC NON-RESPONSE IN INFLAMMATORY BOWEL DISEASE
INCREASED EXPRESSION OF SERPIN E1, A POTENTIAL NEW ACTIVITY MARKER, REFLECTS ENDOSCOPIC ACTIVITY AND THERAPEUTIC NON-RESPONSE IN INFLAMMATORY BOWEL DISEASE

Viktória Szabó  et al.

POTENTIAL BIOMARKER PAI-1 PROMOTES THE DISEASE ACTIVITY AND THERAPEUTIC RESPONSE IN BIOLOGICAL SAMPLES OF INFLAMMATORY BOWEL DISEASES
POTENTIAL BIOMARKER PAI-1 PROMOTES THE DISEASE ACTIVITY AND THERAPEUTIC RESPONSE IN BIOLOGICAL SAMPLES OF INFLAMMATORY BOWEL DISEASES

Viktória Szabó  et al.

AZATHIOPRINE IMPAIRS PANCREATIC DUCTAL CHLORIDE AND BICARBONATE SECRETION BY DISRUPTING CFTR PLASMA MEMBRANE RETENTION IN MICE
AZATHIOPRINE IMPAIRS PANCREATIC DUCTAL CHLORIDE AND BICARBONATE SECRETION BY DISRUPTING CFTR PLASMA MEMBRANE RETENTION IN MICE

Viktória Szabó  et al.

CHARACTERIZATION OF HCO3 SECRETION IN HUMAN PANCREATIC DUCTAL ORGANOID CULTURES
CHARACTERIZATION OF HCO3 SECRETION IN HUMAN PANCREATIC DUCTAL ORGANOID CULTURES

Viktória Szabó  et al.

INVESTIGATING THE ROLE OF ORAI1 CA2+ CHANNEL IN THE PROGRESSION OF CHRONIC PANCREATITIS
INVESTIGATING THE ROLE OF ORAI1 CA2+ CHANNEL IN THE PROGRESSION OF CHRONIC PANCREATITIS

Viktória Szabó  et al.

INTERPLAY OF ORAI1 CA2+ CHANNEL AND CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) IN EPITHELIAL PHYSIOLOGY
INTERPLAY OF ORAI1 CA2+ CHANNEL AND CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR (CFTR) IN EPITHELIAL PHYSIOLOGY

Viktória Szabó  et al.

LDN-071, A NOVEL FIRST-IN-CLASS PEPTIDE-BASED PLASMINOGEN ACTIVATOR INHIBITOR 1, SIGNIFICANTLY REDUCES THE SEVERITY OF EXPERIMENTAL COLITIS IN MICE
LDN-071, A NOVEL FIRST-IN-CLASS PEPTIDE-BASED PLASMINOGEN ACTIVATOR INHIBITOR 1, SIGNIFICANTLY REDUCES THE SEVERITY OF EXPERIMENTAL COLITIS IN MICE

Viktória Szabó  et al.

ADVANCED APICAL MEMBRANE PHYSIOLOGY IS REVEALED BY POLARITY-SWITCHED HUMAN PANCREATIC DUCTAL ORGANOIDS
ADVANCED APICAL MEMBRANE PHYSIOLOGY IS REVEALED BY POLARITY-SWITCHED HUMAN PANCREATIC DUCTAL ORGANOIDS

Viktória Szabó  et al.

LDN-051 A NOVEL FECAL BIOMARKER FOR MONITORING DISEASE ACTIVITY AND THERAPEUTIC RESPONSE IN INFLAMMATORY BOWEL DISEASES – RESULTS OF A PHASE 2 CLINICAL TRIAL
LDN-051 A NOVEL FECAL BIOMARKER FOR MONITORING DISEASE ACTIVITY AND THERAPEUTIC RESPONSE IN INFLAMMATORY BOWEL DISEASES – RESULTS OF A PHASE 2 CLINICAL TRIAL

Viktória Szabó  et al.

Item 1 - 17 / 17
1